NovellusDx closes USD6m funding round
NovellusDx, a specialist in functional genomics, has completed an equity financing of USD6 million backed by Helsinn Investment Fund, Bio Capital Impact Fund, and Windham Venture Partners. This adds to the nearly USD17 million already raised by the company. “We are excited to invest in NovellusDx and support their aim